| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | proteasome-activating activity | 2.35e-04 | 6 | 80 | 2 | GO:0036402 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | HBS1L PSMC1 PSMC2 MTREX DDX41 GFM1 ABCA7 RGS12 DDX3X DNAH11 RAD50 | 2.56e-04 | 775 | 80 | 11 | GO:0017111 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 3.84e-04 | 441 | 80 | 8 | GO:0016887 | |
| GeneOntologyMolecularFunction | helicase activity | 4.34e-04 | 158 | 80 | 5 | GO:0004386 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | HBS1L PSMC1 PSMC2 MTREX DDX41 GFM1 ABCA7 RGS12 DDX3X DNAH11 RAD50 | 5.01e-04 | 839 | 80 | 11 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | HBS1L PSMC1 PSMC2 MTREX DDX41 GFM1 ABCA7 RGS12 DDX3X DNAH11 RAD50 | 5.06e-04 | 840 | 80 | 11 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | HBS1L PSMC1 PSMC2 MTREX DDX41 GFM1 ABCA7 RGS12 DDX3X DNAH11 RAD50 | 5.06e-04 | 840 | 80 | 11 | GO:0016818 |
| GeneOntologyMolecularFunction | ATP-dependent activity | 7.70e-04 | 614 | 80 | 9 | GO:0140657 | |
| Domain | RRM_1 | 3.02e-06 | 208 | 80 | 8 | PF00076 | |
| Domain | RRM | 4.13e-06 | 217 | 80 | 8 | SM00360 | |
| Domain | RRM_dom | 5.75e-06 | 227 | 80 | 8 | IPR000504 | |
| Domain | RRM | 6.33e-06 | 230 | 80 | 8 | PS50102 | |
| Domain | - | 9.75e-06 | 244 | 80 | 8 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 1.46e-05 | 258 | 80 | 8 | IPR012677 | |
| Domain | - | HBS1L YLPM1 PSMC1 PSMC2 DLG2 MTREX DDX41 GFM1 ABCA7 DDX3X DNAH11 HELLS RAD50 | 1.58e-05 | 746 | 80 | 13 | 3.40.50.300 |
| Domain | CSTF2_hinge | 1.81e-05 | 2 | 80 | 2 | IPR025742 | |
| Domain | CSTF2_hinge | 1.81e-05 | 2 | 80 | 2 | PF14327 | |
| Domain | NR5_fam | 1.81e-05 | 2 | 80 | 2 | IPR016355 | |
| Domain | CSTF_C | 1.81e-05 | 2 | 80 | 2 | PF14304 | |
| Domain | CSTF_C | 1.81e-05 | 2 | 80 | 2 | IPR026896 | |
| Domain | P-loop_NTPase | HBS1L YLPM1 PSMC1 PSMC2 DLG2 MTREX DDX41 GFM1 ABCA7 DDX3X DNAH11 HELLS RAD50 | 5.97e-05 | 848 | 80 | 13 | IPR027417 |
| Domain | 26S_Psome_P45 | 2.69e-04 | 6 | 80 | 2 | IPR005937 | |
| Domain | RFX_DNA_binding | 6.40e-04 | 9 | 80 | 2 | PF02257 | |
| Domain | DNA-bd_RFX | 6.40e-04 | 9 | 80 | 2 | IPR003150 | |
| Domain | RFX_DBD | 6.40e-04 | 9 | 80 | 2 | PS51526 | |
| Domain | Helicase_C | 1.15e-03 | 107 | 80 | 4 | PF00271 | |
| Domain | HELICc | 1.15e-03 | 107 | 80 | 4 | SM00490 | |
| Domain | Helicase_C | 1.19e-03 | 108 | 80 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 1.23e-03 | 109 | 80 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.23e-03 | 109 | 80 | 4 | PS51192 | |
| Domain | DEXDc | 1.23e-03 | 109 | 80 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.28e-03 | 110 | 80 | 4 | IPR014001 | |
| Domain | G_TR_1 | 1.37e-03 | 13 | 80 | 2 | PS00301 | |
| Domain | VitD_rcpt | 1.59e-03 | 14 | 80 | 2 | IPR000324 | |
| Domain | - | 1.87e-03 | 57 | 80 | 3 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 1.97e-03 | 58 | 80 | 3 | IPR013088 | |
| Domain | EFTu-like_2 | 2.65e-03 | 18 | 80 | 2 | IPR004161 | |
| Domain | GTP_EFTU_D2 | 2.65e-03 | 18 | 80 | 2 | PF03144 | |
| Domain | G_TR_2 | 2.65e-03 | 18 | 80 | 2 | PS51722 | |
| Domain | TF_GTP-bd_dom | 2.96e-03 | 19 | 80 | 2 | IPR000795 | |
| Domain | PDEase | 2.96e-03 | 19 | 80 | 2 | IPR023088 | |
| Domain | AAA+_ATPase | 3.41e-03 | 144 | 80 | 4 | IPR003593 | |
| Domain | AAA | 3.41e-03 | 144 | 80 | 4 | SM00382 | |
| Domain | PDEase_I | 3.61e-03 | 21 | 80 | 2 | PF00233 | |
| Domain | PDEASE_I | 3.61e-03 | 21 | 80 | 2 | PS00126 | |
| Domain | PDEase_CS | 3.61e-03 | 21 | 80 | 2 | IPR023174 | |
| Domain | - | 3.61e-03 | 21 | 80 | 2 | 1.10.720.30 | |
| Domain | DEAD/DEAH_box_helicase_dom | 3.79e-03 | 73 | 80 | 3 | IPR011545 | |
| Domain | DEAD | 3.79e-03 | 73 | 80 | 3 | PF00270 | |
| Domain | - | 3.96e-03 | 22 | 80 | 2 | 1.10.1300.10 | |
| Domain | SAP | 3.96e-03 | 22 | 80 | 2 | PF02037 | |
| Domain | SAP | 4.32e-03 | 23 | 80 | 2 | SM00513 | |
| Domain | PDEase_catalytic_dom | 4.32e-03 | 23 | 80 | 2 | IPR002073 | |
| Domain | HDc | 4.70e-03 | 24 | 80 | 2 | SM00471 | |
| Domain | HD/PDEase_dom | 4.70e-03 | 24 | 80 | 2 | IPR003607 | |
| Domain | SAP | 5.10e-03 | 25 | 80 | 2 | PS50800 | |
| Domain | SAP_dom | 5.10e-03 | 25 | 80 | 2 | IPR003034 | |
| Domain | Transl_B-barrel | 5.93e-03 | 27 | 80 | 2 | IPR009000 | |
| Domain | ATPase_AAA_CS | 6.82e-03 | 29 | 80 | 2 | IPR003960 | |
| Domain | DEAD_ATP_HELICASE | 7.77e-03 | 31 | 80 | 2 | PS00039 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TRPM6 NCAPD3 HBS1L SAFB IARS1 HPRT1 ENAH HNRNPM SAFB2 PSMC1 TRA2A ZNF207 DLST EIF3A MTREX GRM1 DNAJC7 DDX41 GFM1 STAG2 DDX3X PDXK HNRNPL PCYOX1 HELLS RAD50 | 6.15e-17 | 1425 | 80 | 26 | 30948266 |
| Pubmed | NCAPD3 ZNF609 SAFB RBM12 GATAD2A DOCK8 IARS1 ARID2 HPRT1 SAFB2 PSMC1 ZNF207 MTREX DDX41 MIDEAS STAG2 CSTF2T DDX3X HNRNPL HELLS RAD50 | 4.77e-14 | 1103 | 80 | 21 | 34189442 | |
| Pubmed | SAFB RBM12 GATAD2A CAPN2 YLPM1 SAFB2 CNDP2 CSTF2 TRA2A EIF3A MTREX DNAJC7 DDX41 STAG2 CSTF2T PDXK HELLS RAD50 | 1.29e-11 | 1014 | 80 | 18 | 32416067 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | SAFB GATAD2A IARS1 HPRT1 YLPM1 SAFB2 PSMC1 CSTF2 TRA2A EIF3A MTREX DNAJC7 DDX41 STAG2 DDX3X HNRNPL HELLS RAD50 | 1.52e-11 | 1024 | 80 | 18 | 24711643 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | HBS1L GATAD2A IARS1 ARHGEF1 HPRT1 CAPN2 ENAH HNRNPM PSMC1 PSMC2 EIF3A MTREX DNAJC7 ELP3 DDX41 STAG2 DDX3X HNRNPL HELLS RAD50 | 4.65e-11 | 1415 | 80 | 20 | 28515276 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NCAPD3 ZNF609 SAFB GATAD2A ZSCAN30 YLPM1 HNRNPM SAFB2 CSTF2 TRA2A MTREX DDX41 MIDEAS STAG2 CASZ1 DDX3X HNRNPL HELLS RAD50 | 8.18e-11 | 1294 | 80 | 19 | 30804502 |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | ZNF609 RBM12 ARID2 YLPM1 HNRNPM MTREX MIDEAS CASZ1 HNRNPL RAD50 | 9.35e-11 | 220 | 80 | 10 | 35785414 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TGM2 HBS1L SAFB GATAD2A IARS1 ARHGEF1 CAPN2 HNRNPM SAFB2 PSMC1 PSMC2 DLST EIF3A MTREX ELP3 DDX41 MIDEAS HNRNPL RAD50 | 1.73e-10 | 1353 | 80 | 19 | 29467282 |
| Pubmed | IARS1 HNRNPM PSMC1 PSMC2 TRA2A EIF3A MTREX DNAJC7 DDX41 STAG2 DDX3X HNRNPL HELLS RAD50 | 2.10e-10 | 638 | 80 | 14 | 33239621 | |
| Pubmed | ZNF609 SAFB ARID2 HNRNPM SAFB2 TRA2A MTREX DDX3X HNRNPL RAD50 | 2.57e-10 | 244 | 80 | 10 | 29884807 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | NCAPD3 SAFB IARS1 ARID2 HNRNPM SAFB2 PSMC1 STAG2 DDX3X HNRNPL RAD50 | 2.96e-10 | 332 | 80 | 11 | 32786267 |
| Pubmed | TGM2 SAFB YLPM1 HNRNPM SAFB2 CSTF2 TRA2A ZNF207 DLST EIF3A BAIAP2 MTREX DDX3X HNRNPL | 3.27e-10 | 660 | 80 | 14 | 32780723 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | TCEA2 ZNF609 SAFB GATAD2A ARID2 YLPM1 HNRNPM SAFB2 CSTF2 ZNF207 DDX41 MIDEAS STAG2 DDX3X HNRNPL HELLS | 4.74e-10 | 954 | 80 | 16 | 36373674 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | SAFB YLPM1 HNRNPM SAFB2 PSMC2 TRA2A ZNF207 EIF3A MTREX DNAJC7 DDX41 GFM1 MIDEAS DDX3X HNRNPL RAD50 | 7.96e-10 | 989 | 80 | 16 | 36424410 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | TGM2 HBS1L SAFB GATAD2A IARS1 ARHGEF1 HPRT1 HNRNPM SAFB2 PSMC1 CNDP2 PSMC2 TRA2A EIF3A MTREX DDX41 DDX3X HNRNPL | 8.87e-10 | 1318 | 80 | 18 | 30463901 |
| Pubmed | 2.59e-09 | 153 | 80 | 8 | 28225217 | ||
| Pubmed | HBS1L SAFB YLPM1 ENAH HNRNPM SAFB2 TRA2A MTREX ELP3 DDX41 DDX3X HNRNPL HELLS | 3.19e-09 | 653 | 80 | 13 | 33742100 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | NCAPD3 GCAT IARS1 HPRT1 HNRNPM PSMC1 PSMC2 TRA2A UBAC2 DNAJC7 ELP3 DDX41 GFM1 DDX3X PDXK HNRNPL HELLS | 3.25e-09 | 1257 | 80 | 17 | 37317656 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | TGM2 HBS1L PDE4D RBM12 IARS1 ARHGEF1 HPRT1 CAPN2 ENAH HNRNPM PSMC1 CNDP2 PSMC2 CSTF2 EIF3A DNAJC7 ELP3 DDX3X | 4.19e-09 | 1455 | 80 | 18 | 22863883 |
| Pubmed | SAFB IARS1 HPRT1 HNRNPM PSMC2 DLST EIF3A MTREX DNAJC7 DDX3X HNRNPL RAD50 | 5.03e-09 | 551 | 80 | 12 | 34728620 | |
| Pubmed | HBS1L GATAD2A CAPN2 ENAH PSMC1 PSMC2 DLST MTREX ELP3 GFM1 PCYOX1 RAD50 | 6.02e-09 | 560 | 80 | 12 | 35241646 | |
| Pubmed | PDE4A GATAD2A IARS1 HPRT1 ENAH HNRNPM PSMC1 PSMC2 CSTF2 TRA2A EIF3A MTREX DNAJC7 DDX41 DDX3X HNRNPL | 7.05e-09 | 1153 | 80 | 16 | 29845934 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DOCK8 ARHGEF1 YLPM1 ENAH HNRNPM PSMC1 PSMC2 MTREX DDX41 STAG2 HELLS RAD50 | 9.23e-09 | 582 | 80 | 12 | 20467437 |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | NCAPD3 HBS1L GCAT IARS1 ARID2 HNRNPM ZNF207 EIF3A DNAJC7 DDX41 DDX3X | 1.56e-08 | 486 | 80 | 11 | 30940648 |
| Pubmed | Physiological and pathophysiological characteristics of ataxin-3 isoforms. | 1.81e-08 | 281 | 80 | 9 | 30455355 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | TGM2 PDE4A SAFB HNRNPM PSMC1 TRA2A ZNF207 DLST CASZ1 DDX3X HNRNPL RAD50 | 2.06e-08 | 626 | 80 | 12 | 33644029 |
| Pubmed | NEFH SAFB PDE4D DOCK8 IARS1 ARHGEF1 HNRNPM PSMC1 DLG2 DLST EIF3A BAIAP2 GRM1 ELP3 OPCML PDXK DNAH11 | 2.20e-08 | 1431 | 80 | 17 | 37142655 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | TGM2 SAFB GATAD2A IARS1 HNRNPM SAFB2 PSMC1 TRA2A DLST EIF3A BAIAP2 MTREX DDX41 DDX3X HNRNPL RAD50 | 2.36e-08 | 1257 | 80 | 16 | 36526897 |
| Pubmed | SAFB RBM12 YLPM1 PSMC1 CSTF2 ZNF207 DNAJC7 CSTF2T PDXK HNRNPL | 2.85e-08 | 399 | 80 | 10 | 35987950 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | SAFB RBM12 YLPM1 HNRNPM SAFB2 CSTF2 TRA2A ZNF207 EIF3A DDX41 CSTF2T DDX3X HNRNPL | 3.87e-08 | 807 | 80 | 13 | 22681889 |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | ZNF609 GATAD2A IARS1 ARHGEF1 PSMC1 PSMC2 CSTF2 DLST EIF3A DDX41 DDX3X HNRNPL | 3.98e-08 | 665 | 80 | 12 | 30457570 |
| Pubmed | HBS1L GATAD2A IARS1 HPRT1 HNRNPM PSMC1 PSMC2 ZNF207 DLST EIF3A MTREX DNAJC7 ELP3 DDX3X HNRNPL RAD50 | 5.40e-08 | 1335 | 80 | 16 | 29229926 | |
| Pubmed | NCAPD3 SAFB GATAD2A IARS1 ARID2 HNRNPM SAFB2 TRA2A DLST EIF3A MTREX DDX3X HNRNPL | 6.78e-08 | 847 | 80 | 13 | 35850772 | |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | HNRNPM PSMC1 CNDP2 PSMC2 ZNF207 DLST BAIAP2 DNAJC7 DDX41 DDX3X HNRNPL PCYOX1 | 7.39e-08 | 704 | 80 | 12 | 32994395 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | TGM2 SAFB IARS1 CAPN2 YLPM1 HNRNPM PSMC1 ZNF207 DLST EIF3A BAIAP2 DNAJC7 DDX3X HNRNPL PCYOX1 RAD50 | 7.47e-08 | 1367 | 80 | 16 | 32687490 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | HBS1L ZNF609 SAFB RBM12 GATAD2A HNRNPM ZNF207 DDX3X CCDC102A HELLS | 7.72e-08 | 444 | 80 | 10 | 34795231 |
| Pubmed | HBS1L IARS1 HNRNPM PSMC2 ZNF207 EIF3A MTREX DDX41 DDX3X HNRNPL | 1.28e-07 | 469 | 80 | 10 | 37314180 | |
| Pubmed | Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin. | 1.39e-07 | 170 | 80 | 7 | 16159877 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | SAFB GATAD2A IARS1 YLPM1 HNRNPM EIF3A MTREX DDX41 DDX3X HNRNPL HELLS | 1.43e-07 | 605 | 80 | 11 | 28977666 |
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | 1.69e-07 | 175 | 80 | 7 | 25756610 | |
| Pubmed | Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation. | 2.07e-07 | 269 | 80 | 8 | 30442662 | |
| Pubmed | 2.38e-07 | 274 | 80 | 8 | 34244482 | ||
| Pubmed | 2.94e-07 | 390 | 80 | 9 | 17643375 | ||
| Pubmed | 2.97e-07 | 116 | 80 | 6 | 21549307 | ||
| Pubmed | SAFB HNRNPM SAFB2 PSMC1 CSTF2 DLST MTREX STAG2 DDX3X HNRNPL RAD50 | 3.00e-07 | 652 | 80 | 11 | 31180492 | |
| Pubmed | SAFB IARS1 HPRT1 CAPN2 ENAH HNRNPM PSMC1 CNDP2 PSMC2 DLG2 DLST BAIAP2 GFM1 PDXK | 3.04e-07 | 1139 | 80 | 14 | 36417873 | |
| Pubmed | NCAPD3 IARS1 HPRT1 YLPM1 ENAH HNRNPM PSMC2 ZNF207 DLST EIF3A BAIAP2 HNRNPL | 3.28e-07 | 809 | 80 | 12 | 32129710 | |
| Pubmed | NCAPD3 HBS1L DOCK8 IARS1 HNRNPM PSMC1 PSMC2 DLST EIF3A DNAJC7 DDX41 STAG2 HNRNPL RAD50 | 4.10e-07 | 1168 | 80 | 14 | 19946888 | |
| Pubmed | AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis. | 4.17e-07 | 200 | 80 | 7 | 35546148 | |
| Pubmed | IARS1 HNRNPM PSMC1 PSMC2 UBAC2 EIF3A DNAJC7 GFM1 DDX3X RAD50 | 4.21e-07 | 534 | 80 | 10 | 35032548 | |
| Pubmed | NANOG-dependent function of TET1 and TET2 in establishment of pluripotency. | 4.37e-07 | 27 | 80 | 4 | 23395962 | |
| Pubmed | 4.61e-07 | 203 | 80 | 7 | 35012549 | ||
| Pubmed | HBS1L ARID2 YLPM1 ENAH PSMC2 CSTF2 DNAJC7 MIDEAS CSTF2T RAD50 | 5.42e-07 | 549 | 80 | 10 | 38280479 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 5.82e-07 | 130 | 80 | 6 | 35545047 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | SAFB IARS1 HPRT1 HNRNPM SAFB2 PSMC1 TRA2A DLST EIF3A MTREX HNRNPL | 7.33e-07 | 714 | 80 | 11 | 28302793 |
| Pubmed | ZNF609 RBM12 GATAD2A IARS1 ARID2 YLPM1 PSMC1 PSMC2 CSTF2 EIF3A DNAJC7 MIDEAS HNRNPL HELLS RAD50 | 8.03e-07 | 1429 | 80 | 15 | 35140242 | |
| Pubmed | 8.18e-07 | 441 | 80 | 9 | 31239290 | ||
| Pubmed | 1.06e-06 | 334 | 80 | 8 | 30425250 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SAFB ARID2 YLPM1 HNRNPM SAFB2 CSTF2 TRA2A ZNF207 DLST DDX41 CSTF2T DDX3X HNRNPL | 1.09e-06 | 1082 | 80 | 13 | 38697112 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | IARS1 HPRT1 HNRNPM PSMC1 PSMC2 EIF3A BAIAP2 BCAR3 MTREX DDX41 DDX3X HNRNPL HELLS RAD50 | 1.26e-06 | 1284 | 80 | 14 | 17353931 |
| Pubmed | 1.46e-06 | 613 | 80 | 10 | 22268729 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SAFB RBM12 ARID2 YLPM1 ENAH HNRNPM SAFB2 PSMC2 EIF3A DDX3X HELLS RAD50 | 1.48e-06 | 934 | 80 | 12 | 33916271 |
| Pubmed | SAFB IARS1 HNRNPM TRA2A EIF3A BAIAP2 MTREX MIDEAS DDX3X HNRNPL | 1.51e-06 | 615 | 80 | 10 | 31048545 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | NCAPD3 IARS1 ARHGEF1 CAPN2 HNRNPM PSMC1 PSMC2 CSTF2 UBAC2 DNAJC7 STAG2 HELLS | 1.61e-06 | 942 | 80 | 12 | 31073040 |
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | GATAD2A HPRT1 HNRNPM PSMC1 PSMC2 CSTF2 MTREX DNAJC7 HNRNPL HELLS | 1.72e-06 | 624 | 80 | 10 | 33729478 |
| Pubmed | 1.98e-06 | 491 | 80 | 9 | 36273042 | ||
| Pubmed | DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation. | 2.02e-06 | 89 | 80 | 5 | 22446626 | |
| Pubmed | A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis. | 2.06e-06 | 254 | 80 | 7 | 28431233 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | IARS1 HPRT1 ENAH HNRNPM PSMC1 PSMC2 CSTF2 EIF3A DNAJC7 DDX41 DDX3X HNRNPL RAD50 | 2.11e-06 | 1149 | 80 | 13 | 35446349 |
| Pubmed | PPARγ Interaction with UBR5/ATMIN Promotes DNA Repair to Maintain Endothelial Homeostasis. | 2.14e-06 | 90 | 80 | 5 | 30699358 | |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 3.75e-06 | 179 | 80 | 6 | 36261009 | |
| Pubmed | 3.93e-06 | 46 | 80 | 4 | 20890123 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | HBS1L GCAT ENAH PSMC1 PSMC2 BAIAP2 DNAJC7 DDX41 RGS12 DDX3X RAD50 | 4.07e-06 | 853 | 80 | 11 | 28718761 |
| Pubmed | Histone-binding of DPF2 mediates its repressive role in myeloid differentiation. | 4.20e-06 | 283 | 80 | 7 | 28533407 | |
| Pubmed | 4.65e-06 | 408 | 80 | 8 | 33766124 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | NCAPD3 HPRT1 HNRNPM PSMC1 PSMC2 TRA2A MTREX DDX3X HNRNPL RAD50 | 4.99e-06 | 704 | 80 | 10 | 29955894 |
| Pubmed | A family of splice variants of CstF-64 expressed in vertebrate nervous systems. | 5.23e-06 | 2 | 80 | 2 | 19284619 | |
| Pubmed | Recognition of GU-rich polyadenylation regulatory elements by human CstF-64 protein. | 5.23e-06 | 2 | 80 | 2 | 12773396 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 17029590 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 14587024 | ||
| Pubmed | SAFB1 mediates repression of immune regulators and apoptotic genes in breast cancer cells. | 5.23e-06 | 2 | 80 | 2 | 19901029 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 8543574 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 14681198 | ||
| Pubmed | Enantiomer-specific activities of an LRH-1 and SF-1 dual agonist. | 5.23e-06 | 2 | 80 | 2 | 33335203 | |
| Pubmed | The crystal structures of human steroidogenic factor-1 and liver receptor homologue-1. | 5.23e-06 | 2 | 80 | 2 | 15897460 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 26904944 | ||
| Pubmed | Scavenger receptors mediate the role of SUMO and Ftz-f1 in Drosophila steroidogenesis. | 5.23e-06 | 2 | 80 | 2 | 23637637 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 12972182 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 21081692 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 19077293 | ||
| Pubmed | Low SAFB levels are associated with worse outcome in breast cancer patients. | 5.23e-06 | 2 | 80 | 2 | 19137425 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 23471216 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 17095585 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 16207706 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 21129436 | ||
| Pubmed | Liver receptor homologue-1 expression in ovarian epithelial and granulosa cell tumours. | 5.23e-06 | 2 | 80 | 2 | 23537609 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 26530052 | ||
| Pubmed | LRH-1 May Rescue SF-1 Deficiency for Steroidogenesis: An in vitro and in vivo Study. | 5.23e-06 | 2 | 80 | 2 | 25896302 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 9520403 | ||
| Pubmed | Unravelling the RNA-Binding Properties of SAFB Proteins in Breast Cancer Cells. | 5.23e-06 | 2 | 80 | 2 | 26273616 | |
| Interaction | CEBPA interactions | NCAPD3 ZNF609 SAFB RBM12 GATAD2A DOCK8 IARS1 ARID2 HPRT1 CAPN2 HNRNPM SAFB2 PSMC1 ZNF207 MTREX DDX41 MIDEAS STAG2 CSTF2T DDX3X HNRNPL HELLS RAD50 | 1.64e-10 | 1245 | 78 | 23 | int:CEBPA |
| Interaction | CEBPB interactions | HBS1L GATAD2A IARS1 ARHGEF1 HPRT1 YLPM1 HNRNPM SAFB2 PSMC1 PSMC2 TRA2A ZNF207 DLST EIF3A MTREX DNAJC7 DDX41 GFM1 CSTF2T DDX3X HNRNPL HELLS RAD50 | 2.90e-09 | 1443 | 78 | 23 | int:CEBPB |
| Interaction | EED interactions | NCAPD3 SAFB GATAD2A IARS1 CAPN2 YLPM1 HNRNPM SAFB2 PSMC1 CNDP2 PSMC2 TRA2A EIF3A MTREX DDX41 STAG2 CASZ1 DDX3X HNRNPL HELLS RAD50 | 8.33e-08 | 1445 | 78 | 21 | int:EED |
| Interaction | BIRC3 interactions | SAFB IARS1 HPRT1 ENAH HNRNPM PSMC1 TRA2A ZNF207 DLST EIF3A MTREX DNAJC7 DDX41 GFM1 STAG2 DDX3X PDXK HNRNPL PCYOX1 RAD50 | 1.11e-07 | 1334 | 78 | 20 | int:BIRC3 |
| Interaction | ATXN3 interactions | GCAT IARS1 CAPN2 ENAH HNRNPM PSMC1 PSMC2 UBAC2 DLST EIF3A DNAJC7 HNRNPL | 1.16e-07 | 439 | 78 | 12 | int:ATXN3 |
| Interaction | AR interactions | ZNF609 RBM12 IARS1 ARID2 YLPM1 HNRNPM PSMC1 CNDP2 PSMC2 NR5A1 MTREX DNAJC7 MIDEAS CASZ1 DDX3X HNRNPL RAD50 | 1.87e-07 | 992 | 78 | 17 | int:AR |
| Interaction | SMC5 interactions | TCEA2 ZNF609 SAFB GATAD2A ARID2 YLPM1 HNRNPM SAFB2 CSTF2 ZNF207 DDX41 MIDEAS STAG2 DDX3X HNRNPL HELLS RAD50 | 2.10e-07 | 1000 | 78 | 17 | int:SMC5 |
| Interaction | OBSL1 interactions | SAFB GATAD2A YLPM1 NR5A2 SAFB2 CSTF2 TRA2A EIF3A MTREX DNAJC7 DDX41 MIDEAS STAG2 DDX3X HNRNPL RAD50 | 2.88e-07 | 902 | 78 | 16 | int:OBSL1 |
| Interaction | NUPR1 interactions | TGM2 SAFB YLPM1 HNRNPM SAFB2 CSTF2 TRA2A ZNF207 DLST EIF3A BAIAP2 MTREX DDX3X HNRNPL | 3.18e-07 | 683 | 78 | 14 | int:NUPR1 |
| Interaction | MIR98 interactions | 5.69e-07 | 78 | 78 | 6 | int:MIR98 | |
| Interaction | MIR199A1 interactions | 8.84e-07 | 84 | 78 | 6 | int:MIR199A1 | |
| Interaction | MEN1 interactions | NCAPD3 ZNF609 SAFB GATAD2A IARS1 ARID2 YLPM1 HNRNPM SAFB2 TRA2A DLST NR5A1 EIF3A MTREX DDX41 MIDEAS | 1.65e-06 | 1029 | 78 | 16 | int:MEN1 |
| Interaction | MIRLET7A2 interactions | 1.94e-06 | 96 | 78 | 6 | int:MIRLET7A2 | |
| Interaction | MIR363 interactions | 2.07e-06 | 97 | 78 | 6 | int:MIR363 | |
| Interaction | DOT1L interactions | NCAPD3 SAFB GATAD2A IARS1 ARID2 HNRNPM SAFB2 TRA2A DLST NR5A1 EIF3A MTREX DDX3X HNRNPL | 2.30e-06 | 807 | 78 | 14 | int:DOT1L |
| Interaction | SNRPA interactions | SAFB YLPM1 HNRNPM SAFB2 CSTF2 TRA2A ZNF207 MTREX DDX41 DDX3X HNRNPL | 2.40e-06 | 482 | 78 | 11 | int:SNRPA |
| Interaction | MIR19A interactions | 2.47e-06 | 100 | 78 | 6 | int:MIR19A | |
| Interaction | MIRLET7D interactions | 2.62e-06 | 101 | 78 | 6 | int:MIRLET7D | |
| Interaction | MIRLET7A1 interactions | 3.87e-06 | 108 | 78 | 6 | int:MIRLET7A1 | |
| Interaction | AIM2 interactions | 4.30e-06 | 110 | 78 | 6 | int:AIM2 | |
| Interaction | C9orf78 interactions | HBS1L GATAD2A CAPN2 ENAH PSMC1 PSMC2 DLST MTREX ELP3 GFM1 PCYOX1 RAD50 | 4.40e-06 | 620 | 78 | 12 | int:C9orf78 |
| Interaction | NR2C2 interactions | TGM2 HBS1L SAFB GATAD2A IARS1 ARHGEF1 HPRT1 HNRNPM SAFB2 PSMC1 CNDP2 PSMC2 TRA2A EIF3A MTREX DDX41 DDX3X HNRNPL | 5.08e-06 | 1403 | 78 | 18 | int:NR2C2 |
| Interaction | CPSF6 interactions | TCEA2 SAFB YLPM1 HNRNPM SAFB2 CSTF2 TRA2A MTREX CSTF2T DDX3X HNRNPL | 5.53e-06 | 526 | 78 | 11 | int:CPSF6 |
| Interaction | SSU72 interactions | 5.67e-06 | 66 | 78 | 5 | int:SSU72 | |
| Interaction | BRD7 interactions | NCAPD3 HBS1L GCAT IARS1 ARID2 HNRNPM ZNF207 DLST EIF3A DNAJC7 DDX41 DDX3X | 5.79e-06 | 637 | 78 | 12 | int:BRD7 |
| Interaction | STIP1 interactions | DOCK8 IARS1 HNRNPM PSMC1 PSMC2 TRA2A EIF3A MTREX DNAJC7 DDX41 STAG2 DDX3X HNRNPL HELLS RAD50 | 6.10e-06 | 1006 | 78 | 15 | int:STIP1 |
| Interaction | FUS interactions | SAFB ADCK5 ARID2 HPRT1 YLPM1 HNRNPM SAFB2 CSTF2 TRA2A MTREX DNAJC7 DDX3X HNRNPL | 6.19e-06 | 757 | 78 | 13 | int:FUS |
| Interaction | MIR138-1 interactions | 6.57e-06 | 68 | 78 | 5 | int:MIR138-1 | |
| Interaction | MIR140 interactions | 8.13e-06 | 71 | 78 | 5 | int:MIR140 | |
| Interaction | MIR122 interactions | 8.13e-06 | 71 | 78 | 5 | int:MIR122 | |
| Interaction | MIR29B2 interactions | 8.13e-06 | 71 | 78 | 5 | int:MIR29B2 | |
| Interaction | C9orf72 interactions | NCAPD3 GCAT IARS1 HPRT1 HNRNPM PSMC1 PSMC2 TRA2A UBAC2 DNAJC7 ELP3 DDX41 GFM1 DDX3X PDXK HNRNPL HELLS | 9.25e-06 | 1319 | 78 | 17 | int:C9orf72 |
| Interaction | MIR18A interactions | 9.33e-06 | 73 | 78 | 5 | int:MIR18A | |
| Interaction | MIR20A interactions | 9.97e-06 | 74 | 78 | 5 | int:MIR20A | |
| Interaction | MIR15A interactions | 1.07e-05 | 75 | 78 | 5 | int:MIR15A | |
| Interaction | MIR7-3 interactions | 1.14e-05 | 76 | 78 | 5 | int:MIR7-3 | |
| Interaction | MIR16-1 interactions | 1.14e-05 | 76 | 78 | 5 | int:MIR16-1 | |
| Interaction | MIR199A2 interactions | 1.14e-05 | 76 | 78 | 5 | int:MIR199A2 | |
| Interaction | MIR92A1 interactions | 1.29e-05 | 78 | 78 | 5 | int:MIR92A1 | |
| Interaction | MIR451A interactions | 1.29e-05 | 78 | 78 | 5 | int:MIR451A | |
| Interaction | MIR206 interactions | 1.37e-05 | 79 | 78 | 5 | int:MIR206 | |
| Interaction | MIR1-2 interactions | 1.37e-05 | 79 | 78 | 5 | int:MIR1-2 | |
| Interaction | MIR34C interactions | 1.37e-05 | 79 | 78 | 5 | int:MIR34C | |
| Interaction | MIR143 interactions | 1.46e-05 | 80 | 78 | 5 | int:MIR143 | |
| Interaction | MIR145 interactions | 1.55e-05 | 81 | 78 | 5 | int:MIR145 | |
| Interaction | SUMO2 interactions | NCAPD3 SAFB IARS1 ARID2 HNRNPM SAFB2 PSMC1 STAG2 DDX3X HNRNPL RAD50 | 1.65e-05 | 591 | 78 | 11 | int:SUMO2 |
| Interaction | USP14 interactions | IARS1 HPRT1 HNRNPM PSMC1 CNDP2 PSMC2 DNAJC7 GFM1 DDX3X HNRNPL | 1.85e-05 | 489 | 78 | 10 | int:USP14 |
| Interaction | MIR31 interactions | 1.85e-05 | 84 | 78 | 5 | int:MIR31 | |
| Interaction | MIR7-2 interactions | 1.85e-05 | 84 | 78 | 5 | int:MIR7-2 | |
| Interaction | MIR200B interactions | 1.85e-05 | 84 | 78 | 5 | int:MIR200B | |
| Interaction | KCTD13 interactions | NEFH PDE4D DOCK8 IARS1 ARHGEF1 CAPN2 HNRNPM PSMC1 DLG2 DLST EIF3A BAIAP2 GRM1 ELP3 OPCML PDXK DNAH11 | 1.90e-05 | 1394 | 78 | 17 | int:KCTD13 |
| Interaction | MIR107 interactions | 1.96e-05 | 85 | 78 | 5 | int:MIR107 | |
| Interaction | MIR17 interactions | 1.96e-05 | 85 | 78 | 5 | int:MIR17 | |
| Interaction | MIR93 interactions | 1.96e-05 | 85 | 78 | 5 | int:MIR93 | |
| Interaction | MIR9-1 interactions | 1.96e-05 | 85 | 78 | 5 | int:MIR9-1 | |
| Interaction | MIR16-2 interactions | 1.96e-05 | 85 | 78 | 5 | int:MIR16-2 | |
| Interaction | MIR20B interactions | 2.08e-05 | 86 | 78 | 5 | int:MIR20B | |
| Interaction | CUL4B interactions | SAFB DOCK8 SAFB2 CNDP2 CSTF2 TRA2A ZNF207 NR5A1 CSTF2T DDX3X HELLS RAD50 | 2.20e-05 | 728 | 78 | 12 | int:CUL4B |
| Interaction | CDC5L interactions | DOCK8 ARHGEF1 YLPM1 ENAH HNRNPM PSMC1 PSMC2 TRA2A MTREX DDX41 STAG2 HELLS RAD50 | 2.26e-05 | 855 | 78 | 13 | int:CDC5L |
| Interaction | MIR138-2 interactions | 2.33e-05 | 88 | 78 | 5 | int:MIR138-2 | |
| Interaction | SOX2 interactions | ZNF609 PDE4D GATAD2A ARID2 HPRT1 CAPN2 YLPM1 HNRNPM PSMC2 DLST NR5A1 MTREX DDX41 MIDEAS STAG2 DDX3X HNRNPL | 2.45e-05 | 1422 | 78 | 17 | int:SOX2 |
| Interaction | MIR29C interactions | 2.46e-05 | 89 | 78 | 5 | int:MIR29C | |
| Interaction | MIR221 interactions | 2.59e-05 | 90 | 78 | 5 | int:MIR221 | |
| Interaction | MIR92A2 interactions | 2.59e-05 | 90 | 78 | 5 | int:MIR92A2 | |
| Interaction | MIR1-1 interactions | 2.59e-05 | 90 | 78 | 5 | int:MIR1-1 | |
| Interaction | MIR200C interactions | 2.74e-05 | 91 | 78 | 5 | int:MIR200C | |
| Interaction | WWOX interactions | IARS1 HPRT1 YLPM1 ENAH PSMC1 PSMC2 CSTF2 EIF3A BAIAP2 DNAJC7 HNRNPL | 2.84e-05 | 627 | 78 | 11 | int:WWOX |
| Interaction | MIR155 interactions | 2.88e-05 | 92 | 78 | 5 | int:MIR155 | |
| Interaction | MIR128-1 interactions | 2.88e-05 | 92 | 78 | 5 | int:MIR128-1 | |
| Interaction | MIR214 interactions | 3.04e-05 | 93 | 78 | 5 | int:MIR214 | |
| Interaction | MIR205 interactions | 3.04e-05 | 93 | 78 | 5 | int:MIR205 | |
| Interaction | MIRLET7F1 interactions | 3.20e-05 | 94 | 78 | 5 | int:MIRLET7F1 | |
| Interaction | CHD3 interactions | SAFB GATAD2A IARS1 YLPM1 HNRNPM CSTF2 EIF3A MTREX DDX41 STAG2 DDX3X HNRNPL | 3.23e-05 | 757 | 78 | 12 | int:CHD3 |
| Interaction | GLDC interactions | 3.38e-05 | 321 | 78 | 8 | int:GLDC | |
| Interaction | TOPORS interactions | 3.54e-05 | 96 | 78 | 5 | int:TOPORS | |
| Interaction | MIRLET7C interactions | 3.72e-05 | 97 | 78 | 5 | int:MIRLET7C | |
| Interaction | MIR21 interactions | 3.72e-05 | 97 | 78 | 5 | int:MIR21 | |
| Interaction | MIR106B interactions | 3.91e-05 | 98 | 78 | 5 | int:MIR106B | |
| Interaction | MIR128-2 interactions | 4.11e-05 | 99 | 78 | 5 | int:MIR128-2 | |
| Interaction | RBM39 interactions | SAFB IARS1 HPRT1 YLPM1 HNRNPM SAFB2 PSMC1 TRA2A DLST EIF3A MTREX STAG2 DDX3X HNRNPL | 4.13e-05 | 1042 | 78 | 14 | int:RBM39 |
| Interaction | EIF4G1 interactions | 4.41e-05 | 433 | 78 | 9 | int:EIF4G1 | |
| Interaction | TDH interactions | 4.43e-05 | 3 | 78 | 2 | int:TDH | |
| Interaction | MIRLET7B interactions | 4.52e-05 | 101 | 78 | 5 | int:MIRLET7B | |
| Interaction | MIR25 interactions | 4.52e-05 | 101 | 78 | 5 | int:MIR25 | |
| Interaction | MIRLET7A3 interactions | 4.74e-05 | 102 | 78 | 5 | int:MIRLET7A3 | |
| Interaction | NLN interactions | 4.88e-05 | 52 | 78 | 4 | int:NLN | |
| Interaction | MIR15B interactions | 4.97e-05 | 103 | 78 | 5 | int:MIR15B | |
| Interaction | MIR7-1 interactions | 4.97e-05 | 103 | 78 | 5 | int:MIR7-1 | |
| Interaction | SNRPC interactions | 5.00e-05 | 440 | 78 | 9 | int:SNRPC | |
| Interaction | MIR19B1 interactions | 5.20e-05 | 104 | 78 | 5 | int:MIR19B1 | |
| Interaction | MIR34A interactions | 5.20e-05 | 104 | 78 | 5 | int:MIR34A | |
| Interaction | PRMT1 interactions | SAFB IARS1 HPRT1 YLPM1 HNRNPM PSMC2 DLST EIF3A MTREX DNAJC7 DDX3X HNRNPL RAD50 | 5.33e-05 | 929 | 78 | 13 | int:PRMT1 |
| Interaction | BTF3 interactions | TGM2 PDE4A SAFB HNRNPM PSMC1 TRA2A ZNF207 DLST CASZ1 DDX3X HNRNPL RAD50 | 5.44e-05 | 799 | 78 | 12 | int:BTF3 |
| Interaction | PML interactions | HBS1L ZNF609 SAFB RBM12 GATAD2A HNRNPM ZNF207 DLST EIF3A DDX3X CCDC102A HELLS RAD50 | 5.57e-05 | 933 | 78 | 13 | int:PML |
| Interaction | MIRLET7E interactions | 5.70e-05 | 106 | 78 | 5 | int:MIRLET7E | |
| Interaction | PINK1 interactions | TGM2 GATAD2A IARS1 ARHGEF1 HNRNPM EIF3A DNAJC7 DDX41 DDX3X HNRNPL PCYOX1 | 5.85e-05 | 679 | 78 | 11 | int:PINK1 |
| Interaction | HNRNPUL1 interactions | 6.35e-05 | 351 | 78 | 8 | int:HNRNPUL1 | |
| Interaction | OGT interactions | HNRNPM PSMC1 CNDP2 PSMC2 ZNF207 DLST BAIAP2 DNAJC7 DDX41 DDX3X PDXK HNRNPL PCYOX1 | 6.69e-05 | 950 | 78 | 13 | int:OGT |
| Interaction | MIR34B interactions | 6.80e-05 | 110 | 78 | 5 | int:MIR34B | |
| Interaction | CLUH interactions | 7.14e-05 | 263 | 78 | 7 | int:CLUH | |
| Cytoband | 19p13.3-p13.2 | 2.69e-04 | 14 | 80 | 2 | 19p13.3-p13.2 | |
| Cytoband | 14q32.11 | 4.01e-04 | 17 | 80 | 2 | 14q32.11 | |
| Cytoband | 14q24.3 | 5.91e-04 | 93 | 80 | 3 | 14q24.3 | |
| Cytoband | 12q24 | 8.76e-04 | 25 | 80 | 2 | 12q24 | |
| Cytoband | 11q25 | 9.48e-04 | 26 | 80 | 2 | 11q25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q25 | 1.35e-03 | 31 | 80 | 2 | chr11q25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 2.72e-03 | 797 | 80 | 6 | chr19p13 | |
| Cytoband | 19q13.2 | 3.01e-03 | 164 | 80 | 3 | 19q13.2 | |
| Cytoband | 19q13.1 | 4.19e-03 | 55 | 80 | 2 | 19q13.1 | |
| GeneFamily | RNA binding motif containing | 6.37e-07 | 213 | 62 | 8 | 725 | |
| Coexpression | GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP | 2.69e-06 | 200 | 80 | 7 | M6942 | |
| Coexpression | GARY_CD5_TARGETS_DN | 7.89e-06 | 440 | 80 | 9 | M13893 | |
| Coexpression | GSE10240_CTRL_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN | 3.35e-05 | 199 | 80 | 6 | M298 | |
| Coexpression | GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN | 3.35e-05 | 199 | 80 | 6 | M8388 | |
| Coexpression | GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP | 3.44e-05 | 200 | 80 | 6 | M5797 | |
| Coexpression | GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_DN | 3.44e-05 | 200 | 80 | 6 | M3199 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP | 3.44e-05 | 200 | 80 | 6 | M5781 | |
| Coexpression | GSE19825_IL2RALOW_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_DN | 3.44e-05 | 200 | 80 | 6 | M4302 | |
| Coexpression | DARWICHE_SKIN_TUMOR_PROMOTER_UP | 8.88e-05 | 147 | 80 | 5 | M1131 | |
| ToppCell | facs-BAT-Fat-3m|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-06 | 189 | 80 | 6 | 7ce71f9c81512ed38c804f025908746b4af3aab1 | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-06 | 194 | 80 | 6 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-06 | 194 | 80 | 6 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-05 | 179 | 80 | 5 | 54621d2b3a66e62aa76b7e444118878ed97c1e02 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 180 | 80 | 5 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 180 | 80 | 5 | 788d5fbf688365b5d92d3aa19b9f8e9448f8be5a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-05 | 181 | 80 | 5 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-05 | 184 | 80 | 5 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.03e-05 | 184 | 80 | 5 | cef3ee2a4a0af961aa3b4c92150d423e841ae8c1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-05 | 187 | 80 | 5 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-05 | 188 | 80 | 5 | e30a4ddac0da8cdcf621d98e28e3895cd9307e7a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-05 | 189 | 80 | 5 | 3a295c215b5c18e7c673f92b7af5be523421682c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-05 | 190 | 80 | 5 | 11d3c31167ea71809b4cc3757a0c6ea54a448602 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-05 | 194 | 80 | 5 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 196 | 80 | 5 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| Drug | N-Acetyl-L-leucine [1188-21-2]; Up 200; 23uM; MCF7; HT_HG-U133A | 5.01e-07 | 199 | 80 | 8 | 6462_UP | |
| Drug | Astemizole [68844-77-9]; Down 200; 8.8uM; HL60; HG-U133A | 5.13e-06 | 192 | 80 | 7 | 1365_DN | |
| Drug | testosterone enanthate | PDE4A PDE4D GCAT CAPN2 TRA2A NR5A1 DNAJC7 ABCA7 PDXK PCYOX1 RAD50 | 5.25e-06 | 575 | 80 | 11 | ctd:C004648 |
| Drug | Nicergoline; Down 200; 8.2uM; PC3; HT_HG-U133A | 5.88e-06 | 196 | 80 | 7 | 2058_DN | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 6.08e-06 | 197 | 80 | 7 | 6241_UP | |
| Drug | Ioversol [87771-40-2]; Up 200; 5uM; PC3; HT_HG-U133A | 6.08e-06 | 197 | 80 | 7 | 6726_UP | |
| Drug | Glimepiride [93479-97-1]; Up 200; 8.2uM; HL60; HT_HG-U133A | 6.28e-06 | 198 | 80 | 7 | 2154_UP | |
| Drug | Ozone | TRPM6 CYP2B6 PDE4A LIPE PDE4D HPRT1 NR5A2 PSMC1 PSMC2 DLST LHX5 GCK CYP2S1 BCAR3 STAG2 HELLS | 7.52e-06 | 1273 | 80 | 16 | ctd:D010126 |
| Drug | RP 73401 | 1.06e-05 | 39 | 80 | 4 | CID000154575 | |
| Drug | (4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one | 1.22e-05 | 2 | 80 | 2 | DB06842 | |
| Drug | 4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid | 3.65e-05 | 3 | 80 | 2 | DB08299 | |
| Drug | AQ4N | 3.65e-05 | 3 | 80 | 2 | ctd:C094428 | |
| Drug | GSK 8470 | 3.65e-05 | 3 | 80 | 2 | ctd:C516216 | |
| Drug | tamoxifen aziridine | 6.13e-05 | 22 | 80 | 3 | CID003033894 | |
| Drug | estradiol; Down 200; 0.01uM; PC3; HT_HG-U133A | 6.49e-05 | 195 | 80 | 6 | 5910_DN | |
| Drug | Pentamidine isethionate [140-64-7]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 6.49e-05 | 195 | 80 | 6 | 4396_DN | |
| Drug | Oxamniquine [21738-42-1]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 6.49e-05 | 195 | 80 | 6 | 4124_UP | |
| Drug | 1,1-dimethylbiguanide hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 6.67e-05 | 196 | 80 | 6 | 2_DN | |
| Drug | Hesperetin [520-33-2]; Up 200; 13.2uM; HL60; HG-U133A | 6.67e-05 | 196 | 80 | 6 | 2031_UP | |
| Drug | Trioxsalen [3902-71-4]; Up 200; 17.6uM; MCF7; HT_HG-U133A | 7.06e-05 | 198 | 80 | 6 | 6078_UP | |
| Drug | Hydrochlorothiazide [58-93-5]; Up 200; 13.4uM; PC3; HG-U133A | 7.06e-05 | 198 | 80 | 6 | 1906_UP | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; ssMCF7; HG-U133A | 7.06e-05 | 198 | 80 | 6 | 415_DN | |
| Drug | Piclamilast | 7.28e-05 | 4 | 80 | 2 | DB01791 | |
| Drug | bromfenacoum | 8.47e-05 | 644 | 80 | 10 | ctd:C013418 | |
| Disease | maturity-onset diabetes of the young (implicated_via_orthology) | 3.14e-04 | 10 | 79 | 2 | DOID:0050524 (implicated_via_orthology) | |
| Disease | neuroticism measurement | 7.19e-04 | 909 | 79 | 9 | EFO_0007660 | |
| Disease | nervousness | 8.29e-04 | 16 | 79 | 2 | NCIT_C74532 | |
| Disease | Dyslipidemias | 1.88e-03 | 24 | 79 | 2 | C0242339 | |
| Disease | Dyslipoproteinemias | 1.88e-03 | 24 | 79 | 2 | C0598784 | |
| Disease | chronotype measurement | 2.48e-03 | 882 | 79 | 8 | EFO_0008328 | |
| Disease | neurotic disorder | 2.55e-03 | 101 | 79 | 3 | EFO_0004257 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GRQLEDFRSKRLMGM | 151 | Q92888 | |
| TMRDFGMGKRSVEER | 131 | P20813 | |
| EEMRRNMGVSSGLEL | 571 | O75815 | |
| SRKMLDEGMMLEGFR | 1421 | Q86V15 | |
| GMLGEDVMRAVREHE | 81 | Q96DY2 | |
| RDRFLKMRGMEILGN | 366 | Q68CP9 | |
| DARVRFLGGRLAMML | 56 | Q96DT5 | |
| AREKRRMRLVVDGMG | 71 | Q3MIX3 | |
| RMRLVVDGMGRFGRS | 76 | Q3MIX3 | |
| MMGRRRAFAVDGRDG | 1 | Q8NAV2 | |
| DPRGIDARGMEARAM | 406 | P33240 | |
| DARGMEARAMEARGL | 411 | P33240 | |
| EARAMEVRGMEARGM | 451 | P33240 | |
| REKETRLRDTMRAMG | 571 | Q8IZY2 | |
| EDARLGMMRTGGTIK | 51 | Q9NTZ6 | |
| VVMLKGDTALDMRGR | 1186 | Q92878 | |
| MRAMKGEGSTAEVRE | 481 | Q33E94 | |
| RMQKEMDRGLRLETH | 36 | P35557 | |
| TGEERERGVTMDVGM | 316 | Q9Y450 | |
| LRATEATAMAMGRGE | 61 | Q86YP4 | |
| RLVDMMERGKIGLDF | 326 | O00571 | |
| GLERERKMLEKARMS | 41 | Q9NRZ9 | |
| GMDRVGSEIERMGLV | 426 | P52272 | |
| GSEIERMGLVMDRMG | 431 | P52272 | |
| RMGQTMERIGSGVER | 471 | P52272 | |
| ERMGANNLERMGLER | 556 | P52272 | |
| LERMGLERMGANSLE | 576 | P52272 | |
| TMLALRDLGMGKREG | 131 | Q96SQ9 | |
| FEREEVGGRLATMMV | 66 | Q9UHG3 | |
| QGDRERERGMEISPM | 616 | P27815 | |
| GDRERERGMEISPMC | 646 | Q08499 | |
| MECQLKRGSVDRMRG | 116 | Q14693 | |
| RRMRPLGGRLDESEM | 256 | Q9H2C1 | |
| DTDGRRLSGEMISMK | 336 | Q9HB14 | |
| ARLASRMADDMLKRG | 356 | O75600 | |
| RMADDMLKRGIFVIG | 361 | O75600 | |
| ADRMIDMGFEGDIRT | 346 | Q9UJV9 | |
| LRKDGPLDMRMDGGR | 186 | A6NJ78 | |
| TERLARDVMKEMGGH | 46 | P00492 | |
| GLDGMRIENKGRMST | 266 | Q14982 | |
| GKGLRSEHREKMNRM | 216 | P36957 | |
| AMGELYEREVREMRG | 141 | P12036 | |
| EALLRGEGARGEMMR | 1366 | Q8NF50 | |
| RGMDDDRGPRRGMDD | 1081 | Q14152 | |
| RGMDDDRGPRRGMDD | 1091 | Q14152 | |
| MGDTGLRKRREDEKS | 1 | P82251 | |
| GARSSMDRKMAELRG | 331 | Q96A19 | |
| GFGMLLMEEAERIAR | 496 | Q9H9T3 | |
| REREAPAMGSEEGMR | 421 | Q6PJG2 | |
| GNRAATLMMLGRFRE | 66 | Q99615 | |
| RRRSGAMVKMAAAGG | 26 | P14866 | |
| ARRVMLEGDSEEMGV | 581 | Q15700 | |
| GGRDSRAMETRAMET | 411 | Q9H0L4 | |
| RGMEARGMDARGLEM | 446 | Q9H0L4 | |
| GSGLMEEMSALLARR | 441 | Q8N8S7 | |
| CEGMTVRGLLSAMRR | 291 | Q13255 | |
| RRRQRKMGEDMHTIG | 416 | P17655 | |
| GAVMDSMELERQRGI | 86 | Q96RP9 | |
| GRIRMKELAGMFLSE | 76 | O76038 | |
| MRAVRRGLREGGAMA | 1 | O14772 | |
| KALGMMGLVRRDTAL | 801 | Q05469 | |
| MKLEAVRADRMRGGR | 151 | O00482 | |
| GEGARMVRELFEMAR | 251 | P35998 | |
| VGMRLEAVRADRMRG | 76 | Q13285 | |
| GVAQMSIRMGDIRRG | 816 | Q8NEZ3 | |
| RMNRRRLKGENGMED | 736 | P41252 | |
| EAGLMALRERRMKVT | 401 | P62191 | |
| AGSVVMERIRMDIRK | 211 | O00764 | |
| SVDRREGSRSMMGER | 761 | Q15424 | |
| SMAAGLERNGRMRVK | 366 | Q9UQB8 | |
| GSGERCVMAMLRRRI | 536 | P42695 | |
| EKRGEIRRMMEVAAA | 36 | Q96KP4 | |
| AEKEETGMAMRIRVG | 466 | P21980 | |
| RCRLTRDKKGMDRGM | 306 | O00294 | |
| FQERDGRMVAGKVLM | 181 | Q86W11 | |
| MIQVLSREEMDGGLR | 1766 | Q9BX84 | |
| SREEMDGGLRKAMRV | 1771 | Q9BX84 | |
| RDMGELIEGMRARAF | 391 | O14924 | |
| RRGMDDRGIVILMVD | 526 | P42285 | |
| DPEEDGMMKRRGRQG | 441 | Q8N3U4 | |
| RMGKRVMALLRENED | 306 | A6NFA1 | |
| GVEDKRIMGMQLDRA | 481 | Q9H2E6 | |
| AMERANGMELDGRRI | 176 | Q13595 | |
| SDLEMRNGRGRGKRM | 361 | O15014 | |
| IDRREGSRPMMGDHR | 781 | Q14151 | |
| MMGRREDSREKMNRG | 1061 | P49750 | |
| GMEGIPEKDMDERRR | 81 | O43670 | |
| MMGKEEEIARIARRL | 1 | Q15560 | |
| ARLMEMGFSRGDALE | 311 | Q8NBM4 | |
| NRDMSVRGMEGSLER | 611 | Q7Z4V0 | |
| GAARREELDMDVMRP | 11 | Q6YBV0 |